Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 6/25/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Robin A. Felder PhD

Wrong Dr. Robin A. Felder PhD?

President and Chief Executive Off...

Phone: (434) ***-****  HQ Phone
Email: r***@***.com
Hypogen Inc
3135 Blandemar Dr.
Charlottesville , Virginia 22903
United States

Company Description: Hypogen, Inc., is a biopharmaceutical company focused on the development of novel diagnostic tests and new therapeutics for essential hypertension. Hypertension is...   more

Employment History

Board Memberships and Affiliations


  • PhD
  • Ph.D.
  • B.S. , Chemistry
    College of William and Mary
  • PhD.
163 Total References
Web References
about hypogen, 25 June 2015 [cached]
Hypogen was co-founded by Dr. Robin Felder and Dr. Pedro Jose in 2002 and is headquartered in Charlottesville, VA, adjacent to the University of Virginia Medical Center.
Robin Felder, Ph.D., President and CEO Dr. Felder co-founded Hypogen and currently serves the President and CEO. Dr. Felder is also the Associate Director of Clinical Chemistry and Toxicology, the Director of the Medical Automation Research Center, and a Professor of Pathology at the University of Virginia in Charlottesville, VA. He is also a Visiting Professor of Pathology at the Johns Hopkins University and a Fellow of the Council for High Blood Pressure Research (a council of leading hypertension researchers elected by the American Heart Association).
In addition to his academic career, Dr. Felder has founded and managed several private ventures spun out from the University of Virginia. Prior to his involvement in Hypogen, he co-founded Medical Automation Systems, Inc. (a medical IT company with product in over 150 hospitals), BIOPHILE, Inc. (a company that sells specimen management hardware and software), and Global Cell Solutions (a biotech cell product company) where he continues to serve as the Chair of the Scientific Advisory Board. Dr. Felder also founded the non-profit Association for Laboratory Automation and served as its President and Chair of its Board of Directors. In addition, Dr. Felder serves on the scientific advisory boards of several privately-held medical technology companies, including Genetic Diagnostics, Inc. (Toronto, Canada), Guidance Interactive Technologies (Delano, Minnesota), and BSI Proteomics (Gaithersburg, Maryland).
Dr. Felder has published over 150 basic and clinical research articles, numerous chapters and reviews, and has been awarded 10 patents. He was also Founder and Editor of the Journal of the Association for Laboratory Automation (JALA) and was a member of the editorial boards of Clinical and Experimental Hypertension, Laboratory Information Management, Advance News for Administrators of the Laboratory, and Clinica Chimica Acta. He has received awards such as the Fogarty International Fellowship, the Young Clinical Investigator Award from the Association for Clinical Scientists, and the Young Investigator Award from both the American Federation for Clinical Research and the American Physiological Society. Dr. Felder received his B.S. in Chemistry at the College of William and Mary and his Ph.D. in Biochemistry at Georgetown University.
hypogen press room, 6 Feb 2006 [cached]
Charlottesville, Va., Feb. 6, 2006 -- Researchers led by UVa Health System pathologist Robin Felder, Ph.D., have demonstrated that looking for several variations of genes that control blood pressure can predict the risk for high blood pressure caused by high levels of salt. Once it is fully developed, this effective diagnostic test will be the first of its kind, says Dr. Felder, whose work will be published in the Feb. 23 issue of the journal Clinical Chemistry.
"A genetic test for high blood pressure and/or salt sensitivity will be instrumental in motivating Americans to adopt heart healthy lifestyles and help to improve their overall health and quality of life," Dr. Felder said.
Dr. Sanada is a former UVa pathology fellow who studied and worked with Dr. Felder.
"Through these grant funds, we wish to stimulate broader research in the area of cardiovascular disease, hypertension and salt sensitivity," said Dr. Felder.
"This new genetic information will allow physicians to provide guidance to patients with a family history of hypertension, so they can modify their lifestyles to help prevent kidney failure, heart failure, stroke and blindness that can result from high blood pressure," said Robin A. Felder, principal investigator and professor of pathology at the U.Va. Health System, where the test was developed as part of the study.
"This discovery will lead to a new test for hypertension that will offer the same high quality diagnostic aid to physicians as the test created to diagnose genetic forms of breast cancer," he said.
The National Heart, Lung, Blood Institute (NHLBI) of the National Institutes of Health (NIH) has awarded more than $1.2 million to University of Virginia pathologist Robin A. Felder and his colleagues to study genetic causes of essential hypertension, or high blood pressure of unknown causes.
The research is looking for a genetic cause for high blood pressure or the propensity to develop high blood pressure. In addition, Felder will study salt-sensitive hypertension to determine why, in some people, a high salt diet causes elevated blood pressure or exacerbates blood pressure that is already high, while in others, there is no relationship between salt intake and blood pressure levels.
"Along with Dr. Pedro Jose at Georgetown University, I recently discovered FJ1, a mutated protein that may provide insight into the cause of this elusive disease," Felder said.
Bioinformatics at, 1 Mar 2014 [cached]
Click here to buy Life Science Automation Fundamentals and Applications (Bioinformatics & Biomedical Imaging) by Mingjun Zhang, Bradley J. Nelson and Robin Felder.
by Mingjun Zhang, Bradley J. Nelson and Robin Felder
Robin Felder is director of the Medical Automation Research Center and Professor of Pathology at the University of Virginia. Dr. Felder founded the Association for Laboratory Automation, and was founding Editor of the Journal of the Association for Laboratory Automation.
WellAware Systems, 24 Nov 2012 [cached]
Robin Felder, Ph.D., Founder
Dr. Felder is a Professor of Pathology and Associate Director of Clinical Chemistry at The University of Virginia (UVA) and a Visiting Professor of Pathology at Johns Hopkins University. Over the past 25 years, he has led a multidisciplinary research and early product development group within UVA, resulting in more than 260 publications, $35 million in grants and contracts, and 11 patents. Dr. Felder is also a successful entrepreneur having founded nine companies and he serves on various scientific advisory and business boards.
Other People with the name "Felder":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.